Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.

Castiglioni V, Onorati M, Rochon C, Cattaneo E.

Neurobiol Dis. 2012 Apr;46(1):30-40. doi: 10.1016/j.nbd.2011.12.032.

Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.

Weiss A, Träger U, Wild EJ, Grueninger S, Farmer R, Landles C, Scahill RI, Lahiri N, Haider S, Macdonald D, Frost C, Bates GP, Bilbe G, Kuhn R, Andre R, Tabrizi SJ.

J Clin Invest. 2012 Oct;122(10):3731-6. doi: 10.1172/JCI64565.

Motor and non-motor behaviour in experimental Huntington's disease.

Zeef DH, Vlamings R, Lim LW, Tan S, Janssen ML, Jahanshahi A, Hoogland G, Prickaerts J, Steinbusch HW, Temel Y.

Behav Brain Res. 2012 Jan 15;226(2):435-9. doi: 10.1016/j.bbr.2011.09.041.

Determinants of fitness to drive in Huntington disease.

Devos H, Nieuwboer A, Tant M, De Weerdt W, Vandenberghe W.

Neurology. 2012 Nov 6;79(19):1975-82. doi: 10.1212/WNL.0b013e3182735d11.

[A case of diabetic chorea with ischemic lesions in the anterior limb of the internal capsule].

Nakashima K, Nakajo T, Kato A, Kawamo M, Imaizumi Y, Shimizu Y, Sugie M, Murakami H, Ichikawa H, Izumiyama H.

Brain Nerve. 2012 May;64(5):570-1. Japanese. No abstract available.

Language impairment in Huntington's disease.

Azambuja MJ, Radanovic M, Haddad MS, Adda CC, Barbosa ER, Mansur LL.

Arq Neuropsiquiatr. 2012 Jun;70(6):410-5.

Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease.

Hong SL, Cossyleon D, Hussain WA, Walker LJ, Barton SJ, Rebec GV.

PLoS One. 2012;7(10):e47026. doi: 10.1371/journal.pone.0047026.

Apparent relative hypermetabolism of selective brain areas in Huntington disease and importance of reference region for analysis.

Lee SJ, Lee WY, Kim YK, An YS, Cho JW, Choi JY, Kim BT, Lee KH.

Clin Nucl Med. 2012 Jul;37(7):663-8. doi: 10.1097/RLU.0b013e3182478bf2.

Selective cognitive impairment in the YAC128 Huntington's disease mouse.

Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, Dunnett SB.

Brain Res Bull. 2012 Jun 1;88(2-3):121-9. doi: 10.1016/j.brainresbull.2011.05.010.

Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.

Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD.

Ann Neurol. 2012 Feb;71(2):245-57. doi: 10.1002/ana.22598.

Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging.

Aggarwal M, Duan W, Hou Z, Rakesh N, Peng Q, Ross CA, Miller MI, Mori S, Zhang J.

Neuroimage. 2012 May 1;60(4):2086-95. doi: 10.1016/j.neuroimage.2012.01.141.

Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients.

Fekete R, Davidson A, Ondo WG, Cohen HS.

Parkinsonism Relat Disord. 2012 Aug;18(7):896-8. doi: 10.1016/j.parkreldis.2012.04.029.

TITF-1 gene mutation in a case of sporadic non-progressive chorea. Response to levodopa treatment.

Fons C, Rizzu P, Garcia-Cazorla A, Martorell L, Ormazabal A, Artuch R, Campistol J, Fernandez-Alvarez E.

Brain Dev. 2012 Mar;34(3):255-7. doi: 10.1016/j.braindev.2011.04.007.

Chorea as a first manifestation in young patients with systemic lupus erythematosus who was initially diagnosed with rheumatic Fever.

Albishri JA.

Clin Med Insights Case Rep. 2012;5:19-21. doi: 10.4137/CCRep.S9143.

The Patient Education Program for Huntington's Disease (PEP-HD).

A'Campo LE, Spliethoff-Kamminga NG, Roos RA.

J Huntingtons Dis. 2012;1(1):47-56. doi: 10.3233/JHD-2012-120002.